In internal meetings and leaked documents, Amazon dreams of taking on Google's DeepMind by using machine learning to revolutionize drug discovery, genomics, clinical trials and more

Last week, a group of Amazon scientists and engineers gathered to dream big. The event was all about machine learning, a powerful type of artificial intelligence that has already transformed Amazon's business and those of other tech giants. What was different about this AI conclave was its focus on audacious possibilities in the medical field, such as using ML to revolutionize drug discovery, clinical trials, genomics and related areas. Insider obtained documents that reveal the topics, goals and challenges discussed. Together, they show Amazon's ambition to take on Google's DeepMind, a pioneer in AI-powered scientific discovery.